Recent Examples on the WebThe study on mutagenicity of the molnupiravir metabolite in the Journal of Infectious Diseases earlier this year also tested favipirivir. William A. Haseltine, Forbes, 2 Nov. 2021 Molnupiravir has been tested for mutagenicity in animals before being moved to human trials, where it is being tested for safety. William A. Haseltine, Forbes, 2 Nov. 2021 Mills says most virologists had despaired of it ever finding a real use—in part because of mutagenicity issues that researchers have seen in analyses and trials over the years. Adam Rogers, Wired, 19 Nov. 2021 The first is the drug’s potential mutagenicity, and the possibility that its use could lead to birth defects or cancerous tumors. William A. Haseltine, Forbes, 1 Nov. 2021 Merck has also addressed the mutagenicity concerns from last year, conducting separate trials on animals to determine the risks. Chris Smith, BGR, 8 Mar. 2021